08:00 , Jan 13, 2014 |  BC Week In Review  |  Company News

Miraculins, Cachet Pharmaceutical deal

Miraculins and Cachet mutually agreed to extend the period to negotiate Cachet's acquisition of exclusive rights to commercialize Miraculins' SCOUT DS Non-Invasive Diabetes Screening technology in China by 30 days to Jan. 30. Miraculins and...
07:00 , Oct 7, 2013 |  BC Week In Review  |  Company News

Miraculins, Cachet Pharmaceutical Co. Ltd. deal

Miraculins and Cachet, which is majority state-owned, signed a letter of intent to negotiate Cachet's acquisition of an exclusive license to commercialize Miraculins' SCOUT DS Non-Invasive Diabetes Screening technology in China. Miraculins said the letter...